A randomized study of clofarabine versus clofarabine plus low-dose cytarabine as front-line therapy for patients aged 60 years and older with acute myeloid leukemia and high-risk myelodysplastic syndrome
published in: Blood
date of publication: 2008-06-18
language: English
main subject: leukemia, cytarabine, myelodysplastic syndrome, acute myeloid leukemia
Cites articles 19
- 2006-01-01
- 2006-02-02
- 2005-05-01
Date
Title
Article - wd:Q33843955